Related Experiment Video
Updated: Mar 3, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Fas and Fas ligand gene polymorphisms in Turkish patients with Familial Mediterranean Fever
Emine Gulce Ozel1, Gulay Gulbol Duran1, Muhammet Murat Celik2
1Department of Medical Biology, Faculty of Medicine, Mustafa Kemal University, 31100, Hatay, Turkey.
Abstract:
Familial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disorder characterized by recurrent fever, serositis, abdominal pain, arthritis, arthralgia and erysipelas like erythema. Fas and Fas ligand molecules play a central role in the apoptosis signaling of various cell types including neutrophils. Neutrophils are the major cell population involved in acute inflammation in patients with FMF and the role of Fas and Fas ligand molecules in this cells of FMF patients may be crucial. Therefore, in the present study, we aimed to investigate whether the Fas cell surface receptor gene (FAS); NM_000043.5: c.-671A>G (rs1800682, MvaI) and Fas ligand gene (FASLG), NM_000639.2: c.-844C>T (rs763110, BsrD1) functional polymorphisms in patients with FMF and their relation to the main clinical features of the disease. The polymorphisms in the promoter regions of FAS c.-671A>G and FASLG c.-844C>T were investigated in 97 non-related FMF patients and 70 non-related healthy controls by using PCR-RFLP technique. The frequencies of FAS c-671AG genotype and G allele were not significantly different between FMF patients and healthy subjects. The frequency of FASLG -844TC genotype was found significantly different between the patients with FMF and healthy controls whereas T or C allele frequency was not significantly different between the groups. Haplotype frequencies of the studied polymorphisms were also not significantly different between FMF patients and controls. There were no correlations between the studied FAS c.-671A>G and FASLG c.-844C>T polymorphisms and the main clinical features of FMF such as fever, arthritis, abdominal and chest pain, arthralgia and erysipelas-like erythema. Our findings suggest that FAS c.-671AG genotype or G allele and FASLG c.-844 allele are not to be a risk factor, whereas FASLG c.-844TC genotype may be protective in the studied Turkish population. According to our results we may suggest that although not statistically significant, higher frequencies of FASLG c.-844CC genotype in FMF patients may be related to delayed apoptosis of neutrophils and ultimately cause neutrophilic inflammation by increasing FASLG expression.
Insights
This study investigated genetic variations in Fas (FAS) and Fas ligand (FASLG) genes in Familial Mediterranean Fever (FMF) patients. While FASLG c.-844TC genotype may be protective, neither FAS nor FASLG polymorphisms were linked to FMF clinical features.
Area of Science:
- Genetics
- Immunology
- Molecular Biology
Background:
- Familial Mediterranean Fever (FMF) is an autoinflammatory disorder involving neutrophils.
- Fas (FAS) and Fas ligand (FASLG) are crucial for apoptosis, particularly in neutrophils during inflammation.
Purpose of the Study:
- To investigate the association between FAS c.-671A>G and FASLG c.-844C>T gene polymorphisms and FMF.
- To determine if these polymorphisms correlate with the clinical manifestations of FMF.
Main Methods:
- PCR-RFLP technique was used to analyze FAS and FASLG polymorphisms in 97 FMF patients and 70 healthy controls.
- Genotype and allele frequencies, as well as haplotype frequencies, were compared between groups.
Main Results:
- No significant difference in FAS c.-671A>G genotype or allele frequencies between FMF patients and controls.
- A significant difference in FASLG c.-844TC genotype frequency was observed between FMF patients and controls.
- No correlation found between studied polymorphisms and FMF clinical features (fever, arthritis, pain, erythema).
Conclusions:
- FAS c.-671A>G and FASLG c.-844 allele are unlikely risk factors for FMF in the Turkish population.
- FASLG c.-844TC genotype may offer protection against FMF.
- Higher FASLG c.-844CC genotype frequency in FMF patients might suggest a role in delayed neutrophil apoptosis and inflammation, though not statistically significant.
More Related Videos
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets

